Oramed Pharmaceuticals Inc (ORMP)

Feb 19, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Cut to Sell at StockNews.com - MarketBeat

Feb 19, 2025

Feb 17, 2025

227,239 Shares in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Acquired by Peapod Lane Capital LLC - MarketBeat

Feb 17, 2025

Feb 12, 2025

OraTech to pioneer oral insulin with $75 million investment - MSN

Feb 12, 2025

Feb 12, 2025

Oramed Pharmaceuticals : Ancillary Agreement Completion Protocol and Supplemental Agreement - Marketscreener.com

Feb 12, 2025

Feb 11, 2025

Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch - Simply Wall St

Feb 11, 2025

Feb 11, 2025

Oramed Pharm Amends Joint Venture for OraTech Launch - TipRanks

Feb 11, 2025

Feb 11, 2025

Oramed (ORMP) Stock Skyrockets Amid JV Development Plans - Stocks Telegraph

Feb 11, 2025

Feb 11, 2025

Oramed announces spinoff of protein drug technology - MSN

Feb 11, 2025

Feb 11, 2025

OraTech to pioneer oral insulin with $75 million investment By Investing.com - Investing.com South Africa

Feb 11, 2025

Feb 11, 2025

Oramed Pharmaceuticals Forms Joint Venture to Commercialize Oral Insulin; Shares Rise - Marketscreener.com

Feb 11, 2025

Feb 11, 2025

Oramed Pharmaceuticals to Spin Off Its Protein Oral Delivery Technology - Contract Pharma

Feb 11, 2025

Feb 11, 2025

Oramed stock soars on spinoff plans (ORMP:NASDAQ) - Seeking Alpha

Feb 11, 2025

Feb 11, 2025

Oramed Announces Joint Venture To Develop And Commercialize Oral Insulin -February 11, 2025 at 09:17 am EST - Marketscreener.com

Feb 11, 2025

Feb 11, 2025

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin - PR Newswire

Feb 11, 2025

Feb 11, 2025

Charting the Course: Viking Therapeutics Inc’s VKTX Stock Prospects - The InvestChronicle

Feb 11, 2025

Feb 11, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Rating Lowered by StockNews.com - MarketBeat

Feb 11, 2025

Feb 10, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Share Price Crosses Below 200 Day Moving AverageTime to Sell? - MarketBeat

Feb 10, 2025

Feb 04, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Passes Below 200 Day Moving AverageHere's What Happened - MarketBeat

Feb 04, 2025

Jan 31, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Cross Below Two Hundred Day Moving Average – Here’s Why - Defense World

Jan 31, 2025

Jan 24, 2025

Oramed Pharmaceuticals Extends Maturity Date of Senior Secured Promissory Note in Recent Amendment - Defense World

Jan 24, 2025

Jan 22, 2025

Oramed Pharmaceuticals extends loan maturity, acquires Scilex shares - Investing.com

Jan 22, 2025

Jan 21, 2025

Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025 - The Manila Times

Jan 21, 2025

Jan 21, 2025

Scilex Holding Company Announces Extension of the Maturity - GlobeNewswire

Jan 21, 2025

Jan 18, 2025

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Sees Significant Decrease in Short Interest - MarketBeat

Jan 18, 2025

Jan 14, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Upgraded to “Hold” at StockNews.com - Defense World

Jan 14, 2025

Jan 13, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Raised to Hold at StockNews.com - MarketBeat

Jan 13, 2025

Jan 05, 2025

Oramed Pharmaceuticals Reports Deferral and Consent Agreement for Tranche B Senior Secured Convertible Note - Defense World

Jan 05, 2025

Jan 04, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Lowered to Sell Rating by StockNews.com - MarketBeat

Jan 04, 2025

Dec 28, 2024

ADVANZ PHARMA (OTCMKTS:CXRXF) versus Oramed Pharmaceuticals (NASDAQ:ORMP) Critical Comparison - Defense World

Dec 28, 2024

Dec 27, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Rating Increased to Hold at StockNews.com - MarketBeat

Dec 27, 2024

Dec 20, 2024

StockNews.com Upgrades Oramed Pharmaceuticals (NASDAQ:ORMP) to “Hold” - Defense World

Dec 20, 2024

Dec 18, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Upgraded to Hold at StockNews.com - MarketBeat

Dec 18, 2024

Dec 18, 2024

Oramed secures $13.2 million payment from Scilex - Investing.com

Dec 18, 2024

Dec 18, 2024

Oramed secures $13.2 million payment from Scilex By Investing.com - Investing.com UK

Dec 18, 2024

Dec 16, 2024

Palo Alto pharmaceutical company secures $17M - The Business Journals

Dec 16, 2024

Dec 16, 2024

Scilex Holding Company Announces Early Installment Payment on its Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation - The Manila Times

Dec 16, 2024

Dec 16, 2024

Scilex Holding Company Announces Early Installment Payment - GlobeNewswire

Dec 16, 2024

Dec 13, 2024

Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt - The Eastern Progress Online

Dec 13, 2024

Dec 13, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Pass Above 50 Day Moving AverageHere's What Happened - MarketBeat

Dec 13, 2024

Dec 04, 2024

3 US Penny Stocks With Market Caps Above $40M - Yahoo Finance

Dec 04, 2024

Dec 02, 2024

ORMP: Preparations for New Phase 3 Trial Advance, While ORMP Leverages Balance Sheet Through Recent Agreements - Yahoo Finance

Dec 02, 2024

Nov 20, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Pass Below 200-Day Moving AverageTime to Sell? - MarketBeat

Nov 20, 2024

Nov 12, 2024

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Stock Holdings Lifted by BML Capital Management LLC - MarketBeat

Nov 12, 2024

Nov 10, 2024

Oramed Pharmaceuticals : INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTSAS OF SEPTEMBER 30, 2024 - Marketscreener.com

Nov 10, 2024